Health
Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine
- Government moves to review funding for mRNA vaccines
- Biden administration had awarded contract in its final days
This article is for subscribers only.
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.
The review is part of a government push to examine spending on messenger RNA-based vaccines, the technology that powered Moderna’s Covid vaccine. The bird flu shot contract was awarded to Moderna in the Biden administration’s final days, sending the company’s stock up 13% in the two days following the Jan. 17 announcement.